Skip to main content

Namenda Sales Data

Rank 29 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Namenda U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 29 (2) -6.00% -9.12%
Q3 2013 27 (2) -1.52% -4.14%
Q2 2013 25 4.67% -2.73%
Q1 2013 25 -1.32% -3.55%
Q4 2012 25 (2) 5.09% -0.10%
Q3 2012 27 (8) 6.05% 4.61%
Q2 2012 35 (2) 4.16% -2.87%
Q1 2012 37 2.71% 1.83%
Q4 2011 37 (1) 6.06% -0.44%
Q3 2011 36 (2) -2.67% -2.27%
Q2 2011 34 (5) 5.72% -0.86%
Q1 2011 39 n/a n/a

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.